Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ruey-Long Hong"'
Autor:
Wei‐Li Ma, Ruey‐long Hong, Pei‐Jen Lou, Ming Yao, Shang‐Ju Wu, Chung‐Wu Lin, Chun‐Wei Wang, Chin‐Hao Chang, Ann‐Lii Cheng, Sung‐Hsin Kuo
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) of the head‐and‐neck area primarily involves the Waldeyer ring (WR) and sinonasal area (SN). However, the differential clinical outcomes between patients with WR‐DLBCL and those with S
Externí odkaz:
https://doaj.org/article/31b9d14c5b67479aae5bf16039a43fcb
Autor:
Makoto Tahara, Yasushi Shimizu, Wing Sum Kenneth Li, Naomi Kiyota, Toshimitsu Endo, Masahiro Goto, Jin Hyoung Kang, Tomoya Yokota, Chia Jui Yen, Vijayvel Jayaprakash, Robert L. Ferris, Ruey-Long Hong, Shunji Takahashi, Maura L. Gillison, Shigemichi Iwae, Nobuhiro Hanai
Publikováno v:
Head & Neck. 42:2852-2862
Background The present study evaluated the 2-year survival of the Asian population in the CheckMate 141 trial. Methods The CheckMate 141 trial included patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN).
Publikováno v:
Lasers in Surgery and Medicine. 47:77-87
Background and Objective Long circulating doxorubicin (Dox)-loaded PEGylated liposomes are clinically safer than the free form due to the significant reduction of cardiac toxicity. However, the therapeutic efficacy of the PEGylated liposome could fur
Autor:
Rosalyn A. Juergens, Edwin P. Hui, Goh Boon Cher, Ruey Long Hong, Tan Eng Huat, Anthony T.C. Chan, Waun Ki Hong, Anne Tsao, Shanthi Marur
Publikováno v:
Cancer Medicine
TAS-106, a RNA polymerase inhibitor, was studied in solid tumors with potential clinical benefit and reasonable tolerability. We conducted a multicenter, international phase II trial of TAS-106 in salvage metastatic or recurrent head and neck squamou
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 9:331-341
Aim: An exploratory subgroup analysis of East Asian (EA) patients in a phase III trial was conducted to assess efficacy and safety trends based on ethnicity. Methods: The 795 patients with recurrent or metastatic squamous cell carcinoma of the head a
Publikováno v:
Head & Neck. 28:74-80
Background. A phase II study was conducted to evaluate the safety and efficacy of a gemcitabine plus vinorelbine combination (GV) for patients with cisplatin-resistant nasopharyngeal carcinoma (NPC). Methods. Thirty-nine eligible patients received vi
Autor:
Chi-Cheng Li, Su-Ming Hsu M.D., Hwei-Fang Tien, Jih-Luh Tang, Ih-Jen Su, Ruey-Long Hong, Ming Yao, Yao-Chang Chen
Publikováno v:
Cancer. 100:366-375
BACKGROUND Sinonasal natural killer (NK)/T-cell or T-cell lymphoma behaves quite differently from other lymphomas. The objective of this study was to investigate clinical features, treatment outcomes, and failure patterns in patients with this type o
Publikováno v:
Lasers in Surgery and Medicine. 34:62-72
Graduate Institute of Oral Biology, College of Medicine, National Taiwan University; Taipei 100, TaiwanBackground and Objectives: Photodynamic therapy(PDT) has been proposed as an alternative approach inovercoming multidrug resistance (MDR) phenotype
Autor:
Ruey-Long Hong, Yun-Long Tseng
Publikováno v:
Cancer. 91:1826-1833
BACKGROUND Compared with free drug, sterically stabilized liposomal drug has prolonged circulation time and, thereby, higher tumor selectivity and antitumor activity. The stability in plasma is an important consideration in the formulation of clinica
Publikováno v:
International Journal of Cancer. 80:723-730
A liposome containing diverse synthetic lipid derivatives of polyethylene glycol (PEG) results in smaller distribution volume and longer circulation time in blood and, thus, may improve drug targeting. The characteristics and therapeutic efficacy of